ArticleInternational journal of clinical oncology2021

Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial.

Yihebali Chi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.